Bishop: Oppose embryonic stem cell research
The Big Issue is a magazine sold by homeless people throughout the UK on registered street pitches. As I wrote in the blog of 17 November, our Big Issue pitches have been terminated (see blog of 11 November “Letter of complaint to the chair of The Big Issue Foundation Charity”); and although we can still sell the magazine on the pitches we had for two years, we have no priority whatsoever: we have to leave if the vendors to whom the pitches have been allocated come along, and not stand in on the pitches at all if a vendor is already there – the latter has been experienced by Declan for two days now. The fact that we don’t have pitches any more is particularly serious for me, because I am facing possible prosecution for begging.
The vast majority of emails I send to scientists and academics inviting them to sign Declan’s petition to the UN on research cloning of embryos and stem cells are still being dumped to spam boxes. In fact, as I explained in the blog of 18 November “Our sleeping pitch is soaked”, the spamming is quite severe. Yesterday, I only received six out-of-office autoreplies from 320 emails; on Wednesday, it was one from 99 emails. No surprise then that only one scientist signed from 419 emails - last week it was two signatories from 640 emails; three weeks ago, one signatory from 1,072 emails. The petition to date has been signed by 584 scientists and academics, including 24 Nobel Laureates.
James Thomson at Tuesday’s 10-year celebration of his hESC breakthrough
I have also written that since the termination of our Big Issue pitches, I have had to adapt my blogs because we are now restricted to the free 3-hour maximum computer use per day at Idea Store Whitechapel library that our local council imposed on each of our membership cards on 1 February. Emphasis now is on the product of my research so that as soon as I have a laptop I am in a position to build within two weeks a website for our campaign in support of embryonic stem (ES) cell research and therapeutic cloning, also known as somatic cell nuclear transfer (SCNT). Applications will be central to this website; also the institutes, labs and people involved. For a way to develop the navigation menu I have Greenpeace International – see here; also the homepage will be loosely based on theirs (for more about the campaign website, see blog of 1 November “Can a cell have a soul?”).
My thinking behind this website is that once the general public is exposed to the work of scientists and clinicians, the funding their work attracts and the potential for clinical cures and therapies for debilitating diseases and disorders, the misinformation and fear that the Catholic church and conservative evangelical groups continue to spread will be seen straight through. A recent statement written by Bishop Robert Carlson of Saginaw, Michigan to Catholic voters on Proposal 2, the amendment to the Michigan Constitution allowing research on embryos that were created for fertility treatments and would otherwise be discarded, serves as an example. “Because it is scientifically unnecessary, because it goes too far and because it is based on reprehensible moral principles, I call on all Catholics in the Diocese of Saginaw to oppose Proposal 2,” the Bishop wrote. His statement also asserted that the use of adult stem cells “has already played a role in the treatment and cure of over 70 types of diseases” (a claim that has been widely discredited), and that the use of embryonic stem cells “has resulted in zero treatments or cures.” Not only was Proposal 2 approved, but Detroit News exit polling showed 56 percent of voters who identified themselves as Catholic supported the measure – overall the measure passed by a 53-47 margin.
Scientists generally agree it’s crucial to push forward rapidly in all three key areas of stem cell research: embryonic stem cells, adult stem cells and induced pluripotent (or “reprogrammed”) stem cells. Around the world, these three kinds of stem cells are under intense study for possible treatments for conditions from spinal cord injuries to juvenile diabetes. Scientists argue that it would be shortsighted to pursue only one kind because each may hold particular promise for understanding and treating specific diseases. Results in one area of research will continue to shed light on work in the others. The capacity of embryonic stem cells to turn into virtually any other kind of cell obviously gives them the most potential for organ and tissue replacement (ScienceDaily, 14/10).